-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Australian Dividend Stocks To Watch In October 2026

Simply Wall St·10/11/2026 19:32:52
语音播报

Bond yields are surging worldwide and income investors are feeling it. Cash and term deposits suddenly look more interesting, yet many Australian dividend stocks still offer yields above 3% that are backed by earnings and consistent payout records. That mix of income and discipline can appeal when markets are choppy. This article walks through three higher yielding options from a curated screen of well covered, stable dividends with a track record of growth.

The stocks covered below are just a sample, and the full screen surfaced 36 more dividend payers with similarly compelling stories that are not discussed here. If you want to identify and analyze the highest conviction income ideas right now, head straight to the Dividend Powerhouses (3%+ Yield) screener.

Medibank Private (ASX:MPL)

Overview: Medibank Private is an Australian health insurer that collects recurring premiums for hospital and extras cover, complemented by health services and related insurance.

Operations: Medibank Private generates about A$8.6b in Health Insurance revenue and A$635 million from Medibank Health, almost entirely in Australia.

Market Cap: A$12.8b

Medibank Private sits in this dividend screen because regular premiums from its health insurance policies help support a yield above 3% that investors can actually use as income.

"The expansion and scaling of primary care clinics, virtual health, and home care offerings position Medibank to benefit from the shift in consumer preferences toward preventative care and at-home healthcare, helping to differentiate its offering, limit claims inflation, and improve net margins."

The real test will come if one unseen cost pressure shifts enough to squeeze the margins that now support the payout.

If that pressure builds, you will want the full narrative for Medibank Private to see how Medibank Private’s income story could accelerate or stall from here.

ASX:MPL Revenue & Expenses Breakdown as at Oct 2026
ASX:MPL Revenue & Expenses Breakdown as at Oct 2026

ARB (ASX:ARB)

Overview: ARB Corporation designs and manufactures aftermarket 4WD accessories and light-metal gear like bull bars, suspension kits and canopies that help support recurring, cash-generative sales.

Operations: ARB generates around A$706.6 million from motor vehicle accessories and light metal engineering, primarily across Australasia, Thailand, the USA and other export markets.

Market Cap: A$1.47b

ARB matters for a dividend screen like this because its aftermarket automotive accessories, from bull bars to touring gear, are designed for regular replacement and upgrades, which helps underpin the kind of recurring cash flows investors look for when assessing dividend coverage.

"The company now has offices in the US, Europe and the Middle East, exports to over 100 countries, and operates manufacturing facilities in Australia, Thailand and Czech Republic. This provides a solid foundation for continued expansion."

The real economic test for ARB’s dividend appeal arrives if one unseen pressure starts to squeeze the accessories margins that currently support it.

If that pressure ever bites, read the full narrative for ARB to see whether margin risk is being masked or whether ARB’s global footprint is quietly accelerating its edge.

ASX:ARB Revenue & Expenses Breakdown as at Oct 2026
ASX:ARB Revenue & Expenses Breakdown as at Oct 2026

nib holdings (ASX:NHF)

Overview: nib holdings runs private health and related insurance across Australia and New Zealand, with Australian Residents Health Insurance providing core, recurring premium income aligned with a well covered 3%+ dividend profile.

Operations: nib holdings generates about A$3.0b from Australian Residents Health Insurance, with further A$431.8 million from New Zealand Insurance and smaller contributions from international, travel, Thrive and health services.

Market Cap: A$3.2b

nib holdings slots neatly into this dividend screen because its Australian Residents Health Insurance arm collects subscription-like premiums that give you clearer line of sight on cash coming in to support regular payouts, even as newer businesses reshape how the group manages health costs.

"Expansion of health management and preventative care offerings (telehealth, wellbeing programs, in-home care, no/known gap networks) is broadening revenue streams, improving customer retention, and actively managing claims inflation, positively impacting both top-line growth and future claims ratios."

The real dividend story now turns on how one unresolved cost pressure influences the gap between those steady premiums and what nib ultimately pays out in claims.

To see how that cost pressure could be accelerating or masking nib holdings’ dividend appeal, read the full narrative for nib holdings for the full picture.

ASX:NHF Revenue & Expenses Breakdown as at Oct 2026
ASX:NHF Revenue & Expenses Breakdown as at Oct 2026

Seeking Fresh Alternatives Before They Fly

Fresh ideas move first, and laggards get caught holding what momentum already left behind. Scan these focused shortlists before the crowd prices them in, and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.